Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full Year 2010 Financial Results
Revenues for the Fourth Quarter and Full Year Increased to $194 Million and $732 Million
View HTML
Toggle Summary Integra LifeSciences Acquires an Exclusive Worldwide License for Novel Minimally Invasive Expandable Interbody Fusion Technology
PLAINSBORO, N.J., Feb. 17, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.
View HTML
Toggle Summary Integra LifeSciences Introduces Advanced Orthobiologics for Extremity Reconstruction
PLAINSBORO, N.J., Feb. 16, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of Trel-XPress™ Demineralized Bone Matrix, expanding its portfolio of bone grafting substitutes for the orthopedic extremity reconstruction surgeon, which includes
View HTML
Toggle Summary Integra LifeSciences Introduces Allograft Cancellous Sponge
PLAINSBORO, N.J., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) announced today the launch of Integra™ Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The sponge-like handling characteristics of Integra™ Allograft
View HTML
Toggle Summary Integra LifeSciences to Present at the Canaccord Genuity Musculoskeletal Conference
PLAINSBORO, N.J., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Brian Larkin, President, Global Spine, and Head of Strategic Development of Integra, will present at the Canaccord Genuity Musculoskeletal Conference.
View HTML
Toggle Summary Integra LifeSciences to Host Its Fourth Quarter 2010 Earnings Results Conference Call on February 24, 2011
PLAINSBORO, N.J., Jan. 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2010 financial results on Thursday, February 24 th , 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
View HTML
Toggle Summary Integra LifeSciences to Present at the 29th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Jan. 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Stuart Essig, Chief Executive Officer of Integra, will present at the 29 th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Wednesday,
View HTML
Toggle Summary Integra LifeSciences Expands Integra(TM) Endoscopic Gastroc Release System (EGR) Product Line
EGR System Available in New Size for Expanded Surgical Applications
View HTML
Toggle Summary Integra LifeSciences to Present at Piper Jaffray's Healthcare and the J.P. Morgan Small and Mid Cap Conferences
PLAINSBORO, N.J., Nov. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two upcoming conferences. Mr. John B. Henneman, III, Executive Vice President and Chief Financial Officer of Integra, will present at the following two
View HTML
Toggle Summary NJBIZ Honors Integra LifeSciences as One of New Jersey's 2010 Fifty Fastest Growing Companies
PLAINSBORO, N.J., Nov. 17, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it was honored for the second year in a row as one of New Jersey's Fifty Fastest Growing Companies by NJBIZ, one of New Jersey's leading statewide business newspapers.
View HTML